InVivo Therapeutics Holdings Profit Margin 2006-2018 | NVIV

Current and historical gross margin, operating margin and net profit margin for InVivo Therapeutics Holdings (NVIV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. InVivo Therapeutics Holdings net profit margin as of September 30, 2018 is 0%.
InVivo Therapeutics Holdings Annual Profit Margins
InVivo Therapeutics Holdings Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.015B $0.000B
InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $137.409B 27.16
Medtronic (MDT) Ireland $121.535B 17.77
Stryker (SYK) United States $72.819B 26.70
Boston Scientific (BSX) United States $52.168B 25.43
Baxter (BAX) United States $39.788B 25.45
Zimmer Biomet Holdings (ZBH) United States $25.879B 16.57
Smith & Nephew SNATS (SNN) United Kingdom $17.424B 0.00
Canopy Growth (CGC) Canada $14.802B 0.00
ResMed (RMD) United States $14.533B 27.56
Aurora Cannabis (ACB) Canada $9.364B 66.07
Bio-Rad Laboratories (BIO) United States $9.204B 52.51
Hill-Rom Holdings (HRC) United States $6.966B 21.55
Perrigo (PRGO) Ireland $6.355B 10.30
Insulet (PODD) United States $5.761B 1943.60
GW Pharmaceuticals (GWPH) United Kingdom $4.977B 0.00
ICU Medical (ICUI) United States $4.744B 29.53
Haemonetics (HAE) United States $4.355B 38.63
Hutchison China MediTech (HCM) China $3.802B 0.00
Agios Pharmaceuticals (AGIO) United States $3.664B 0.00
Neogen (NEOG) United States $3.153B 48.42
NuVasive (NUVA) United States $2.938B 25.63
Quidel (QDEL) United States $2.527B 22.80
Aphria (APHA) $2.418B 107.33
National Vision Holdings (EYE) United States $2.298B 45.20
Cardiovascular Systems (CSII) United States $1.337B 960.00
HEXO (HEXO) $1.317B 0.00
VAREX IMAGING (VREX) United States $1.274B 24.95
Phibro Animal Health (PAHC) United States $1.273B 18.29
AtriCure (ATRC) United States $1.095B 0.00
MacroGenics (MGNX) United States $0.957B 0.00
Lantheus Holdings (LNTH) United States $0.914B 24.70
Cerus (CERS) United States $0.842B 0.00
Omeros (OMER) United States $0.836B 0.00
PetIQ (PETQ) United States $0.835B 23.90
NanoString Technologies (NSTG) United States $0.726B 0.00
Meridian Bioscience (VIVO) United States $0.716B 21.32
Eagle Pharmaceuticals (EGRX) United States $0.674B 22.95
OraSure Technologies (OSUR) United States $0.671B 29.41
TG Therapeutics (TGTX) United States $0.619B 0.00
LeMaitre Vascular (LMAT) United States $0.587B 27.92
Evolus (EOLS) United States $0.577B 0.00
Surmodics (SRDX) United States $0.556B 80.90
Quanterix (QTRX) United States $0.531B 0.00
BioLife Solutions (BLFS) United States $0.350B 144.46
Insys Therapeutics (INSY) United States $0.342B 0.00
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.325B 0.00
Utah Medical Products (UTMD) United States $0.313B 20.33
Bovie Medical (APYX) United States $0.271B 0.00
Owens & Minor (OMI) United States $0.265B 3.67
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.242B 0.00
Cytosorbents (CTSO) United States $0.237B 0.00
Zynex (ZYXI) United States $0.142B 15.21
Fonar (FONR) United States $0.140B 7.48
Surface Oncology (SURF) United States $0.123B 0.00
Chimerix (CMRX) United States $0.103B 0.00
Female Health (VERU) United States $0.097B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
InfuSystems Holdings (INFU) United States $0.089B 0.00
United-Guardian (UG) United States $0.087B 20.02
CAS Medical Systems (CASM) United States $0.071B 0.00
Neurotrope (NTRP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 18.50
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.033B 0.00
Senestech (SNES) United States $0.032B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14